'Phospholipase a2' presentation slideshows

PAIN KILLERS AND YOUR KIDNEY..

868 views • 56 slides

Colorectal Cancer (CRC)

Colorectal Cancer (CRC). Epidemiology, Risk Factors Symptoms, Stages, Therapy 3) Molecular Biology & Pathology Screening. EPIDEMIOLOGY. one of the most common cancers in the world US: 4 th most common cancer (after lung, prostate, and breast cancers)

972 views • 51 slides

Colorectal Cancer (CRC)

Colorectal Cancer (CRC). Epidemiology, Risk Factors Symptoms, Stages, Therapy 3) Molecular Biology & Pathology Screening. EPIDEMIOLOGY. one of the most common cancers in the world US: 4 th most common cancer (after lung, prostate, and breast cancers)

878 views • 51 slides

Percutaneous Treatment of LUMBAR disc herniations by ozone DISCOLYSIS

Percutaneous Treatment of LUMBAR disc herniations by ozone DISCOLYSIS. Alper Muradov M.D. St.Sofia Hospital Sofia,Bulgaria. Epidemiology.

604 views • 49 slides

Lipid Chemistry

Lipid Chemistry . Dr. S.Chakravarty MD . Specific Learning objectives:. At the end of this session the student should be able to :- List the various lipases acting on triglycerides in different parts of the body List the components of Phospholipids and Glycolipids

1.26k views • 43 slides

Anesco Interventional Pain Institute

Treatment Regimens for Acute and Chronic Pain Patients: How to Progress All Injured Workers to Working Status. Anesco Interventional Pain Institute. What is Acute Pain?. Physiologic response to tissue damage Warning signals damage/danger Helps locate problem source

484 views • 36 slides

PANCREAS Dr . Zainab H.H. Dept. of physiology College of medicine Al- Nahrain University

PANCREAS Dr . Zainab H.H. Dept. of physiology College of medicine Al- Nahrain University. Learning objectives Describe the pancreatic secretion Describe the function of cystic fibrosis transmembrane conductance regulator (CFTR)

356 views • 34 slides

Manipulation of the Immune Response

Manipulation of the Immune Response. Chapter 14. http://www.nearingzero.net/screen_res/nz360.jpg. Objectives. Discuss modes of action of common immunosuppressive drugs Describe uses of monoclonal antibodies in immune disorders and cancer Explain how anti-tumor immune responses are generated

766 views • 30 slides

Fever in the ICU

Paul Jones PYG2 Family Medicine. Fever in the ICU. So what?.

545 views • 24 slides

Anti-inflammatory Drugs

Anti-inflammatory Drugs. # Lab 4 #. Inflammation: it is a biological response of vascular tissues to harmful stimuli, such as pathogens, damaged cells, or irritants. Inflammation may ends with either :. Complete healing of tissues. Permanent destruction of tissues. Signs of inflammation.

431 views • 24 slides

Sustained Dexamethasone Drug Delivery System

Sustained Dexamethasone Drug Delivery System. Ozurdex and Novadur Implant. First approved pharmacotherapy for macular edema following BRVO and CRVO. Dr. Bharti Kashyap Kashyap Memorial Eye Hospital. A biodegradable dexamethasone implant Drug incorporated into polymer matrix

932 views • 19 slides

453 views • 17 slides

Autacoids

Autacoids. Objectives: To describe the synthesis, receptors and functions of histamine, eicosanoids ,nitric oxide , angiotensin, kinins & 5-HT. To study the agents which enhance or block their effects. Titles Very important Extra information Terms.

147 views • 12 slides

Open Journal of Pediatrics & Neonatal Care

A common goal in pediatric oncology is a treatment protocol that minimizes risk and maximizes success. The overall survival rate of children with solid tumor metastasis (Stage IV) has shown little improvement in that the extent of the relocation of metastatic cells, and their progression, is not well understood. To better understand the limits of metastasis, an alternative treatment strategy is discussed; based on maladaptive immunity. A skin cream having natural and recombinant allergens, associated with immunologic adjuvants, is vectored into the cancer patient by topical dermal absorption. After that, humoral immunity increases the expression of cross-reactive Immunoglobulin-E (cIgE) primed effector cells, designed to decrease the incidence and prevalence of endogenous proteins that support the metastatic environment. The objective of this review is to explore an alternative cancer-immunotherapy intended to increase the overall survival rate and quality-of-life for children and adolescents struggling with solid tumor metastasis.

44 views • 3 slides

Open Journal of Pediatrics & Neonatal Care

A common goal in pediatric oncology is a treatment protocol that minimizes risk and maximizes success. The overall survival rate of children with solid tumor metastasis (Stage IV) has shown little improvement in that the extent of the relocation of metastatic cells, and their progression, is not well understood. To better understand the limits of metastasis, an alternative treatment strategy is discussed; based on maladaptive immunity. A skin cream having natural and recombinant allergens, associated with immunologic adjuvants, is vectored into the cancer patient by topical dermal absorption. After that, humoral immunity increases the expression of cross-reactive Immunoglobulin-E (cIgE) primed effector cells, designed to decrease the incidence and prevalence of endogenous proteins that support the metastatic environment. The objective of this review is to explore an alternative cancer-immunotherapy intended to increase the overall survival rate and quality-of-life for children and adolescents struggling with solid tumor metastasis.

46 views • 3 slides